Bank Of America Corp Lexaria Bioscience Corp. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Bank Of America Corp holds 126 shares of LEXX stock, worth $201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126
Previous 115
9.57%
Holding current value
$201
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.54MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY460KShares$736,0000.01% of portfolio
-
Invenomic Capital Management LP Boston, MA411KShares$657,1690.04% of portfolio
-
Geode Capital Management, LLC Boston, MA167KShares$266,6860.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA127KShares$203,8920.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL60.6KShares$97,0240.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $9.52M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...